Everardo Macias, Patrick Tomboc Eamonn F. Healy, Chemistry Department,

Slides:



Advertisements
Similar presentations
Fundamentals of Biochemistry
Advertisements

Enzymes.  Describe the characteristics of biological catalysts (enzymes).  Compare inorganic catalysts and biological catalysts (enzymes).  Describe.
Chapter 7 Chem 341 Suroviec Fall I. Introduction The structure and mechanism can reveal quite a bit about an enzyme’s function.
Hypothetical substrate docking in enzyme’s active site. Substrate is geometrically and electronically compatible with active site. Enzymes are also.
Enzymes Have properties shared by all catalysts Enhance the rates of both forward and reverse reactions so equilibrium is achieved more rapidly Position.
Quantitative Structure-Activity Relationships (QSAR) Comparative Molecular Field Analysis (CoMFA) Gijs Schaftenaar.
Enzymes as Drug Targets - a Closer Look Transition state analogs and “suicide substrates”
Bioinformatics IV Quantitative Structure-Activity Relationships (QSAR) and Comparative Molecular Field Analysis (CoMFA) Martin Ott.
Organic Chemistry 4 th Edition Paula Yurkanis Bruice Irene Lee Case Western Reserve University Cleveland, OH ©2004, Prentice Hall Chapter 30 The Organic.
Two Substrate Reactions
Probing Mechanisms of Peptide Bond Formation & Catalysis Using Models Model of Koga Uses molecular recognition by a crown ether to bind a model of the.
Enzyme activity is measured by the amount of product produced or the amount of substrate consumed. The rate of the enzymatic reaction is measured by the.
The Nature of the Active Site Questions we want to ask: 1.Looking at the reactants and products, what type of reaction has occurred Hydrolysis, Condensation,
Review Enzyme “constants” Reversible inhibition
Thrombin and Blood Clotting Thrombin is the final enzyme in the coagulation cascade (Figure 1) at sites of vascular injury and serves as the link between.
3. The chemistry of life 3.6 Enzymes. Enzymes: are globular proteins that work as catalysts – they speed up chemical reactions without being altered themselves.
Chapter 5 Enzymes. Enzymes as organic catalysts Enzyme is for lowering of activation energy.Enzyme is for lowering of activation energy.
Daniel Brown. D9.1 Discuss the use of a compound library in drug design. Traditionally, a large collection of related compounds are synthesized individually.
Synthetic Approach to 5,6-Benzo-1-azabicyclo[2.2.2]octan- 2-one: A Lactam having Zero Resonance Energy Meghan Tobin, Dr. Arthur Greenberg, Jessica Morgan.
Quantifying the drug-target binding affinity. Receptors as targets (Receptors are 45% of current drug targets) Receptors are areas of proteins found in.
Overview of Kinetics Rate of reaction M/sec Rate constant sec -1, M -1 sec -1 Conc. of reactant(s ) Velocity of reaction 1 st order reaction-rate depends.
DE NOVO DESIGN OF A THYMIDYLATE KINASE INHIBITOR.
Synthesis and Retrosynthesis of Peptidomimetic Inhibitors - Thrombin Presented by: Kevin Condel.
1. Chemometrices:  Signal processing  Classification & pattern reccognation  Experimental design  Multivariative calibration  Quantitative Structure.
Review session for exam-III Lectures The concept of “induced fit” refers to the fact that: A. Enzyme specificity is induced by enzyme-substrate.
Enzyme Mechanisms and Inhibition
Use of Machine Learning in Chemoinformatics Irene Kouskoumvekaki Associate Professor December 12th, 2012 Biological Sequence Analysis course.
Properties of Enzymes. Enzymes are catalysts What properties would ideal catalysts have?
20/03/2008 Dept. of Pharmaceutics 1. Use of BIOINFORMATICS in Pharmaciutics 2  Presented By  Shafnan Nazar  Hamid Nasir 
3D- QSAR. QSAR A QSAR is a mathematical relationship between a biological activity of a molecular system and its physicochemical parameters. QSAR attempts.
NSAIDS – Aspirin, Ibuprofen, Celebrex and Beyond.
Enzyme Kinetics and Inhibition
Identifying Applicability Domains for Quantitative Structure Property Relationships Mordechai Shacham a, Neima Brauner b Georgi St. Cholakov c and Roumiana.
Physicochemical Properties of Drugs in relation to Drug Action Roselyn Aperocho Naranjo, RPh, MPH USPF, College of Pharmacy
 I can describe the structure and explain the significance and functions of enzymes in biological systems › I can describe why an investment of activation.
Paola Gramatica, Elena Bonfanti, Manuela Pavan and Federica Consolaro QSAR Research Unit, Department of Structural and Functional Biology, University of.
LECTURE 4: Principles of Enzyme Catalysis Reading: Berg, Tymoczko & Stryer: Chapter 8 ENZYME An ENZYME is a biomolecular catalyst that accelerates the.
QSAR Study of HIV Protease Inhibitors Using Neural Network and Genetic Algorithm Akmal Aulia, 1 Sunil Kumar, 2 Rajni Garg, * 3 A. Srinivas Reddy, 4 1 Computational.
2 Enzymes The Hill equation describes the behavior of enzymes that exhibit cooperative binding of substrate 1. some enzymes bind their substrates.
ENZYMES 2-4
Selection of Molecular Descriptor Subsets for Property Prediction Inga Paster a, Neima Brauner b and Mordechai Shacham a, a Department of Chemical Engineering,
Paul Hagey, Eamonn F. Healy, St. Edward’s University,
Computer-aided drug discovery (CADD)/design methods have played a major role in the development of therapeutically important small molecules for several.
Chapter 16.6 & 16.7 Enzymes & Enzyme Actions
Chapter 20 Enzymes and Vitamins
Binding features that promote catalysis
Enzymes Enzymes speed up the cell’s chemical reactions The cell uses catalysis to drive (speed up) biological reactions –Catalysis is accomplished by enzymes,
Enzyme Rate Enhancement
Use of Machine Learning in Chemoinformatics
Investigation of the enzymatic processes depending on the type of reaction.
Biochemical Reaction Rate: Enzyme Kinetics What affect do enzymes and enzyme inhibitors have on enzyme catalysis on a quantitative level? Lipitor inhibits.
Biochemistry 412 Enzyme Kinetics II April 1st, 2005.
Pharmaceutical Approaches to Antiviral Drug Discovery
Lecture 5:Enzymes Ahmad Razali Ishak
How Do We Control Material Processes at the Level of Electrons? Progress on Grand Challenge New Horizons for Grand Challenge Remaining ChallengeRefreshed.
Molecular Modeling in Drug Discovery: an Overview
Serine Proteases Components of the enzymatic pocket:
PROTEINS AS DRUG TARGETS:
Hierarchical Classification of Calculated Molecular Descriptors
Chemistry 501 Handout 6 Enzymes Chapter 6
Many factors influence the activity of an enzyme
An Introduction to Medicinal Chemistry 3/e PROTEINS AS DRUG TARGETS:
Bioreactors Engineering
An Introduction to Medicinal Chemistry 3/e PROTEINS AS DRUG TARGETS:
Chapter 6 CHM 341 Fall 2016 Suroviec.
Serine proteases have a reactive serine
ENZYME Enzymes as organic catalysts. Factor affecting enzyme activity.
Lecture 8 Enzyme Kinetics
Michael A. McDonough, Christopher J. Schofield  Chemistry & Biology 
Presentation transcript:

Peptidomimetic Inhibitors : An Integrated Synthetic and Theoretical Approach to their Design Everardo Macias, Patrick Tomboc Eamonn F. Healy, Chemistry Department, St. Edward’s University, Austin TX 78704

Abstract Peptidomimetics represent a powerful approach to pharmaceutical treatments based on enzymatically controlled reactions. Peptidomimetics are simply small organic molecules that serve to mimic the transition state of the natural substrate and thus serve to competitively inhibit the enzyme process. We are focusing on the design and synthesis of inhibitors for the serine protease thrombin. Thrombin plays a critical role in the formation of insoluble fibrin that can lead to life threatening medical conditions. Our synthetic scheme utilizes hydroxy-aldehydes in the synthesis of polypeptide isoteres for active site inhibition. QSAR studies aid in the understanding of the steric and hydrophobic requirements of the enzymaticbinding sites.

Enzyme Thrombin, a sub-class of the hydrolyases is a serine protease that promotes blood clotting Thrombin has an active site consisting of the catalytic triad: Ser 195, His 57 and Asp 102

Enzyme BindingSite In addition thrombin has three binding sites, labelled as S1, S2 and S3, that determine the strength and specificity of binding The lipophilicity of S3 has been well determined S3 S2 S1

Peptidomimetics Saquinavir Small peptide-like molecules that mimic transition state of substrate and work by competitive inhibiting binding of the natural substrate Peptide analog must be stable Drug must be a reversible inhibitor of the enzyme but can be irreversible if the enzyme is unique to the disease Saquinavir

Project Design Design a polypeptide isotere based on a natural thrombin substrate (Phe-Pro-Arg tripeptide), shown on the right Optimize a generalized scheme for isotere synthesis Model the S2 and S3 steric and hydrophobic requirements

Project Use Quantitative Structure-Activity Relationships (QSAR) to identify optimum R2 and R3 binding fragments Synthesize the isotere, shown in red on the right, designed to mimic the serine-195 mediated transition state

Retrosynthesis & Synthesis

Results >70% 3100 cm-1, sharp; 2950 cm-1 ; 1610 cm -1, weak d 7.7-7.8, multiplet, 2H ; d 0.4, singlet, 9H d 7.8-7.9, multiplet, 2H ;d 3.6,multiplet,1H d 1.2-1.5, multiplet, 4H

Structure-Activity Results from Ref 2 R3 R2 Ki (nm) CH3 benzyl (S) 17 CH3 phenethyl (R) 550 CH3 phenethyl (S) 235 CH3 phenylpropyl (R) 100 CH3 phenylpropyl (S) 4 H benzyl (R) 1112 H benzyl (S) 8

QSAR Quantitative structure-activity relationships (QSAR) represent an attempt to correlate structural or property descriptors of compounds with their activities. These physicochemical descriptors, including parameters describing hydrophobicity, topology, electronic effects and steric effects, can be determined empirically or by computational methods. Once a correlation between structure and activity/property is found, new compounds can be screened to select those with the desired properties. Activities in which QSAR has found wide application include biological assays, chemical measurements, environmental risk assessment and de novo drug design.

QSAR Methodology Linear regression analysis of the predicted versus observed activity/property is most commonly used to develop the QSAR relationship. The higher the r2 value the better the fit. The technique of leave-one-out cross-validation, quantified as rCV, is used to assess the predictive power of the QSAR model. Two parameters, molecular connectivity and valence connectivity, developed by Kier and Hall were used extensively in this study. While these are fundamentally topological parameters they have been shown to contain electronic as well as structural information.

Connectivity Indices

Results Preliminary results, summarized by the plot of the predicted (y-axis) versus experimental (x-axis) binding constants, clearly show that a functional predictive model of the steric and electronic requirements of the S2 and S3 binding sites can be constructed. Initial results seem to indicate the energetic descriptors are more useful as predictors than simple topological properties. This work continues.

Results

Results

References Acknowledgements Alessandro Dondoni, et al.; Synthesis of TSTs and Reactions with Carbonyl Compounds; J. Org. Chem. 1988, 53, 1748-1761 Benoit Bachand , et al.; Synthesis and Structure-Reactivity of Potent Bicyclic Lactam Thrombin Inhibitors; Bioinorg. & Med. Chem. 1999, 9, 913-918 Acknowledgements We gratefully acknowledge the support of the Welch Foundation in the form of a Departmental Research Grant